Skip to main content
OpenTrials
Completed

NCT Number: NCT04407117

Appendicitis During the National Lockdown During the COVID-19 Pandemic

The study aims to examine whether a nationwide lock-down with an entire population subjugated to social distancing reduces the incidence of appendicitis. If a reduction is detected it supports the hypothesis that infectious disease may play a role in the etiology of appendicitis.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Registered in the Danish National Patient Register during the study period

Exclusion criteria

None

Treatment and study plan

Lock-down and social distancing

Behavioral

Lock-down and social distancing during COVID-19 pandemic

Primary outcomes

  1. Appendectomy

    Time frame: 5 weeks

    Appendectomy or other surgery for appendicitis

Secondary outcomes

  1. Postoperative length of stay

    Time frame: 30 days

    Postoperative length of stay

  2. Mortality

    Time frame: 30 days

    Overall mortality

  3. Incidence of complicated appendicitis

    Time frame: 5 weeks

    Perforated appendicitis or periappendicular abscess

Sponsors and collaborators

Lead sponsor

Claus Anders Bertelsen, PhD, MD

Other

Registry information

Official study title

Change in the Incidence of Appendicitis in a Controlled Environment During the National Lockdown Throughout the COVID-19 Pandemic

Important dates

Study start
2017
Primary completion
2020
Study completion
2020
First posted
May 29, 2020
Registry last updated
Jun 19, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.